These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 29141053

  • 1. Clinical and prognostic value of hTERT mRNA expression in patients with non-small-cell lung cancer.
    Zalewska-Ziob M, Dobija-Kubica K, Biernacki K, Adamek B, Kasperczyk J, Bruliński K, Ostrowska Z.
    Acta Biochim Pol; 2017; 64(4):641-646. PubMed ID: 29141053
    [Abstract] [Full Text] [Related]

  • 2. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
    Metzger R, Vallbohmer D, Müller-Tidow C, Higashi H, Bollschweiler E, Warnecke-Eberz U, Brabender J, Baldus SE, Xi H, Berdel WE, Serve H, Hoelscher AH, Schneider PM.
    Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
    [Abstract] [Full Text] [Related]

  • 3. Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer.
    Sirera R, Bremnes RM, Cabrera A, Jantus-Lewintre E, Sanmartín E, Blasco A, Del Pozo N, Rosell R, Guijarro R, Galbis J, Sánchez JJ, Camps C.
    J Thorac Oncol; 2011 Feb; 6(2):286-90. PubMed ID: 21252717
    [Abstract] [Full Text] [Related]

  • 4. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.
    Miura N, Nakamura H, Sato R, Tsukamoto T, Harada T, Takahashi S, Adachi Y, Shomori K, Sano A, Kishimoto Y, Ito H, Hasegawa J, Shiota G.
    Cancer Sci; 2006 Dec; 97(12):1366-73. PubMed ID: 17052260
    [Abstract] [Full Text] [Related]

  • 5. Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer.
    Hara H, Yamashita K, Shinada J, Yoshimura H, Kameya T.
    Lung Cancer; 2001 Nov; 34(2):219-26. PubMed ID: 11679180
    [Abstract] [Full Text] [Related]

  • 6. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma.
    Fujita Y, Fujikane T, Fujiuchi S, Nishigaki Y, Yamazaki Y, Nagase A, Shimizu T, Ohsaki Y, Kikuchi K.
    Cancer; 2003 Sep 01; 98(5):1008-13. PubMed ID: 12942569
    [Abstract] [Full Text] [Related]

  • 7. Expression of telomerase hTERT in human non-small cell lung cancer and its correlation with c-myc gene.
    Geng Z, Zhang D, Liu Y.
    Chin Med J (Engl); 2003 Oct 01; 116(10):1467-70. PubMed ID: 14570602
    [Abstract] [Full Text] [Related]

  • 8. Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer.
    Zhu CQ, Cutz JC, Liu N, Lau D, Shepherd FA, Squire JA, Tsao MS.
    Br J Cancer; 2006 May 22; 94(10):1452-9. PubMed ID: 16641908
    [Abstract] [Full Text] [Related]

  • 9. hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer.
    Wang L, Soria JC, Kemp BL, Liu DD, Mao L, Khuri FR.
    Clin Cancer Res; 2002 Sep 22; 8(9):2883-9. PubMed ID: 12231532
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: the European Early Lung Cancer Project.
    Van den Berg RM, Brokx H, Vesin A, Field JK, Brambilla C, Meijer CJ, Sutedja GT, Heideman DA, Postmus PE, Smit EF, Snijders PJ.
    Int J Oncol; 2010 Aug 22; 37(2):455-61. PubMed ID: 20596673
    [Abstract] [Full Text] [Related]

  • 11. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
    Yuan A, Yu CJ, Shun CT, Luh KT, Kuo SH, Lee YC, Yang PC.
    Int J Cancer; 2005 Jul 01; 115(4):545-55. PubMed ID: 15704107
    [Abstract] [Full Text] [Related]

  • 12. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L, Shan W, Zhang Y, Lv X, Li X, Wei C.
    Pathol Oncol Res; 2016 Jan 01; 22(1):161-7. PubMed ID: 26453197
    [Abstract] [Full Text] [Related]

  • 13. Status of the Parkinson's disease gene family expression in non-small-cell lung cancer.
    Liu QX, Zheng H, Deng XF, Zhou D, Dai JG.
    World J Surg Oncol; 2015 Aug 07; 13():238. PubMed ID: 26245297
    [Abstract] [Full Text] [Related]

  • 14. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
    Tang R, Zhong T, Dang Y, Zhang X, Li P, Chen G.
    Clin Transl Oncol; 2016 Apr 07; 18(4):360-8. PubMed ID: 26307752
    [Abstract] [Full Text] [Related]

  • 15. CUG-binding protein 1 (CUGBP1) expression and prognosis of non-small cell lung cancer.
    Jiao W, Zhao J, Wang M, Wang Y, Luo Y, Zhao Y, Tang D, Shen Y.
    Clin Transl Oncol; 2013 Oct 07; 15(10):789-95. PubMed ID: 23359188
    [Abstract] [Full Text] [Related]

  • 16. Ornithine decarboxylase mRNA expression in curatively resected non-small-cell lung cancer.
    Grimminger PP, Schneider PM, Metzger R, Vallböhmer D, Danenberg KD, Danenberg PV, Hölscher AH, Brabender J.
    Clin Lung Cancer; 2010 Mar 01; 11(2):114-9. PubMed ID: 20199977
    [Abstract] [Full Text] [Related]

  • 17. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.
    Qian Y, Du Z, Xing Y, Zhou T, Chen T, Shi M.
    Mol Med Rep; 2017 Nov 01; 16(5):6034-6040. PubMed ID: 28849037
    [Abstract] [Full Text] [Related]

  • 18. The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients.
    Mavridis K, Gueugnon F, Petit-Courty A, Courty Y, Barascu A, Guyetant S, Scorilas A.
    Br J Cancer; 2015 Apr 28; 112(9):1527-35. PubMed ID: 25867273
    [Abstract] [Full Text] [Related]

  • 19. Association of PD-1, PD-L1, and CTLA-4 Gene Expression and Clinicopathologic Characteristics in Patients With Non-Small-Cell Lung Cancer.
    Lafuente-Sanchis A, Zúñiga Á, Estors M, Martínez-Hernández NJ, Cremades A, Cuenca M, Galbis JM.
    Clin Lung Cancer; 2017 Mar 28; 18(2):e109-e116. PubMed ID: 27816393
    [Abstract] [Full Text] [Related]

  • 20. Prognostic Value of PD-L1 mRNA Sequencing Expression Profile in Non-Small Cell Lung Cancer.
    Sepesi B, Nelson DB, Mitchell KG, Gibbons DL, Heymach JV, Vaporciyan AA, Swisher SG, Roszik J.
    Ann Thorac Surg; 2018 Jun 28; 105(6):1621-1626. PubMed ID: 29510096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.